| 76.73 -0.09 (-0.12%) | 08-12 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 90.42 | 1-year : | 105.61 |
| Resists | First : | 77.41 | Second : | 90.42 |
| Pivot price | 73.47  |
|||
| Supports | First : | 71.82 | Second : | 68.37 |
| MAs | MA(5) : | 75.48 |
MA(20) : | 73 |
| MA(100) : | 67.89 |
MA(250) : | 72.5 |
|
| MACD | MACD : | 1.7 |
Signal : | 1.3 |
| %K %D | K(14,3) : | 93.1 |
D(3) : | 88.7 |
| RSI | RSI(14): 67  |
|||
| 52-week | High : | 89.83 | Low : | 58.88 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ COO ] has closed below upper band by 12.1%. Bollinger Bands are 12.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 77.23 - 77.63 | 77.63 - 77.93 |
| Low: | 74.45 - 74.87 | 74.87 - 75.18 |
| Close: | 76.07 - 76.77 | 76.77 - 77.31 |
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
Mon, 10 Aug 2026
Cooper Companies Target of Unusually Large Options Trading (NASDAQ:COO) - MarketBeat
Sun, 09 Aug 2026
Assenagon Asset Management S.A. Buys 457,938 Shares of The Cooper Companies, Inc. $COO - MarketBeat
Sat, 08 Aug 2026
The Cooper Companies, Inc. $COO Shares Sold by Bank of America Corp DE - MarketBeat
Fri, 07 Aug 2026
Could Zacks’ Upgrade Reveal a Shift in Cooper Companies’ (COO) Earnings Quality Narrative? - simplywall.st
Fri, 07 Aug 2026
The Cooper Companies, Inc. (NASDAQ:COO) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Wed, 05 Aug 2026
The Cooper Companies, Inc. (COO) Stock Forecasts - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 0 (M) |
| Shares Float | 193 (M) |
| Held by Insiders | 0.6 (%) |
| Held by Institutions | 105.2 (%) |
| Shares Short | 7,920 (K) |
| Shares Short P.Month | 7,260 (K) |
| EPS | 1.17 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 42.27 |
| Profit Margin | 5.5 % |
| Operating Margin | -2.9 % |
| Return on Assets (ttm) | 2.5 % |
| Return on Equity (ttm) | 2.8 % |
| Qtrly Rev. Growth | 7.9 % |
| Gross Profit (p.s.) | 14.2 |
| Sales Per Share | 21.68 |
| EBITDA (p.s.) | 4.54 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 953 (M) |
| Levered Free Cash Flow | 424 (M) |
| PE Ratio | 65.02 |
| PEG Ratio | 0.6 |
| Price to Book value | 1.81 |
| Price to Sales | 3.53 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|